PMID- 12739117 OWN - NLM STAT- MEDLINE DCOM- 20040628 LR - 20181113 IS - 1432-2218 (Electronic) IS - 0930-2794 (Linking) VI - 17 IP - 8 DP - 2003 Aug TI - Effectiveness of laparoscopic fundoplication in relieving the symptoms of gastroesophageal reflux disease (GERD) and eliminating antireflux medical therapy. PG - 1200-5 AB - BACKGROUND: Recent reports have suggested that antireflux surgery should not be advised with the expectation of elimination of medical treatment. We reviewed our results with laparoscopic fundoplication as a means of eliminating the symptoms of gastroesophageal reflux disease (GERD), improving quality of life, and freeing patients from chronic medical treatment for GERD. METHODS: A total of 297 patients who underwent laparoscopic fundoplication (Nissen, n = 252; Toupet, n = 45) were followed for an average of 31.4 months. Preoperative evaluation included endoscopy, barium esophagram, esophageal manometry, and 24-h pH analysis. A preoperative and postoperative visual analogue scoring scale (0-10 severity) was used to evaluate symptoms of heartburn, regurgitation, and dysphagia. A GERD score (2-32) as described by Jamieson was also utilized. The need for GERD medications before and after surgery was assessed. RESULTS: At 2-year follow-up, the average symptom scores decreased significantly in comparison to the preoperative values: heartburn from 8.4 to 1.7, regurgitation from 7.2 to 0.7, and dysphagia from 3.7 to 1.0. The Jamieson GERD score also decreased from 25.7 preoperatively to 4.1 postoperatively. Only 10% of patients were on proton pump inhibitors (PPI) at 2 years after surgery for typical GERD symptoms. A similar percentage of patients (8.7%) were on PPI treatment for questionable reasons, such as Barrett's esophagus, "sensitive" stomach, and irritable bowel syndrome. Seventeen patients (5.7%) required repeat fundoplication for heartburn ( n = 9), dysphagia ( n = 5), and gas/bloating ( n = 3). CONCLUSIONS: Laparoscopic fundoplication can successfully eliminate GERD symptoms and improve quality of life. Significant reduction in the need for chronic GERD medical treatment 2 years after antireflux surgery can be anticipated. FAU - Papasavas, P K AU - Papasavas PK AD - Minimally Invasive Surgical Program, West Perm Allegheny Health System, 4800 Friendship Ave., Pittsburgh, PA 15212, USA. ppapasav@wpahs.org FAU - Keenan, R J AU - Keenan RJ FAU - Yeaney, W W AU - Yeaney WW FAU - Caushaj, P F AU - Caushaj PF FAU - Gagne, D J AU - Gagne DJ FAU - Landreneau, R J AU - Landreneau RJ LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Review DEP - 20030513 PL - Germany TA - Surg Endosc JT - Surgical endoscopy JID - 8806653 RN - 0 (Antacids) RN - 0 (Anti-Ulcer Agents) RN - 0 (Antifoaming Agents) RN - 0 (Histamine H2 Antagonists) SB - IM MH - Adolescent MH - Adult MH - Aged MH - Aged, 80 and over MH - Antacids/therapeutic use MH - Anti-Ulcer Agents/therapeutic use MH - Antifoaming Agents/therapeutic use MH - Combined Modality Therapy MH - Deglutition Disorders/etiology MH - Female MH - Follow-Up Studies MH - Fundoplication/*methods MH - Gastroesophageal Reflux/complications/drug therapy/etiology/*surgery MH - Histamine H2 Antagonists/therapeutic use MH - Humans MH - *Laparoscopy MH - Male MH - Middle Aged MH - Pain/etiology MH - Pressure MH - Retrospective Studies MH - Severity of Illness Index MH - Treatment Outcome RF - 22 EDAT- 2003/05/10 05:00 MHDA- 2004/06/29 05:00 CRDT- 2003/05/10 05:00 PHST- 2002/03/14 00:00 [received] PHST- 2002/10/18 00:00 [accepted] PHST- 2003/05/10 05:00 [pubmed] PHST- 2004/06/29 05:00 [medline] PHST- 2003/05/10 05:00 [entrez] AID - 10.1007/s00464-002-8910-y [doi] PST - ppublish SO - Surg Endosc. 2003 Aug;17(8):1200-5. doi: 10.1007/s00464-002-8910-y. Epub 2003 May 13.